Ultium Cells' Factory In Tennessee To Produce More Battery Cells via insideevs.com
Tom Gallagher, Ultium Cells LLC vice president of operations said:
“This investment will allow us to provide our customer GM more battery cells faster and support GM’s aggressive EV launch plan in the coming years. Ultium Cells is taking the appropriate steps to support GM’s plan for more than 1 million units of EV capacity in North America by mid-decade.”“Ultium Cells will play a critical role in making GM’s commitment to an all-electric future a reality.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
GM and LG battery joint venture secure $2.5B DOE loanUltium Cells, a joint venture between GM and LG, plans three battery plants in the U.S.
Read more »
GM Developing Ultium-Based EV Sedan That Could Replace the Chevy MalibuCurrently only confirmed for China, the electric Malibu successor could look like the Chevy FNR-XE sedan concept and possibly come to America.
Read more »
Ultra Thin Printed Solar Cells From MIT Can Electrify Everything (With Video)Researchers at MIT have devised ultra-thin printed solar cells that outperform conventional solar cells on an output by weight basis.
Read more »
Video: MIT engineers develop paper-thin solar cells that can power any surfaceThe ultralight solar cells are made of semiconducting inks using printing processes that can be scaled in the future to large-area manufacturing.
Read more »
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells - Nature MedicineA bedside-to-bench analysis identifies single-chain variable fragment linker length as an important component of chimeric antigen receptor (CAR) structure and suggests that, in contrast to CD28-based CAR T cells, tonic signaling can be beneficial for 4-1BB-based CAR T cell function.
Read more »
A teen's cancer is in remission after she received new cells edited with CRISPRA young girl entered remission after receiving an experimental cancer treatment.
Read more »